drugset / Trial / NCT07107672

Mass Balance Study of [14C]X842 in Healthy Adult Male Subjects

NCT07107672

Phase 1 Completed 6 enrolled Jiangsu Sinorda Biomedicine Co., Ltd
NaSingle-groupOpen-labelBasic science

Summary

This study is a single-site, single-dose, non-randomized, open-label study to assess the absorption, metabolism, and excretion profile of \[14C\]X842 in healthy adult male subjects. The study plans to enroll 6 to 8 healthy male subjects in China to ensure at least 4 evaluable subjects.

Timeline

Start
2022-06-15
Primary completion
2022-07-07
Completion
2022-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Linaprazan glurate Small molecule 50 mg Oral